1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted , modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408 of Regulation S-K.
+Added: During the three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted , modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408 of Regulation S-K.
3.1 Amended and Restated Articles of Incorporation of the Company, as amended and restated effective June 27, 2022, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 28, 2022.
−Removed: 3.2 Bylaws of the Company, as amended effective October 4, 2023, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 5, 2023.
−Removed: Form of 4.000% Notes due 2028, incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on September 15, 2025.
−Removed: Form of 4.600% Notes due 2032, incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on September 15, 2025.
−Removed: Form of 5.000% Notes due 2036, incorporated by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on September 15, 2025.
−Removed: Form of 5.700% Notes due 2055, incorporated by reference to Exhibit 4.5 to the Company's Current Report on Form 8-K filed on September 15, 2025.
+Added: 3.2 By laws of the Company, as amended effective October 4, 2023, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 5, 2023.
4.5 Upon the request of the U.S.
Securities and Exchange Commission, the Company will furnish copies of any other instruments defining the rights of holders of long-term debt of the Company or its subsidiaries.
−Removed: Form of Employment Agreement between the Company and each of the following:
−Removed: Wessling and Ryan R.
+Added: Form of Incentive Compensation Plan Nonqualified Stock Option Award Agreement for 2026.
+Added: Form of Incentive Compensation Plan Restricted Stock Unit Award Agreement for 2026.
+Added: Form of Incentive Compensation Plan Performance Stock Unit Award Agreement for 2026.
+Added: Form of CEO Incentive Compensation Plan Performance Stock Unit Award Agreement for 2026 .
+Added: Form of Incentive Compensation Plan Restricted Stock Unit Retention Award Agreement for 2026.
31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act Rules, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
ELEVANCE HEALTH, INC.
−Removed: October 21, 2025 By:
+Added: April 22, 2026 By:
/ S / M ARK B.
1 unchanged sentence
(Duly Authorized Officer and Principal Financial Officer)
−Removed: October 21, 2025 By:
+Added: April 22, 2026 By:
/ S / R ONALD W.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.